Mark A. Gregory
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Ubiquitin and proteasome pathways 6
- Cell death mechanisms and regulation 5
- Histone Deacetylase Inhibitors Research 4
- Protein Degradation and Inhibitors 2
- Hematology 10
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- Stephan Hann (9 shared papers)Ying Qi (1 shared paper)Julie A. Vrana (2 shared papers)Aaron M. Domina (2 shared papers)Ruth W. Craig (2 shared papers)James DeGregori (11 shared papers)Vadym Zaberezhnyy (8 shared papers)Ying Qi (2 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Oncogene (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular and Cellular Biology (2 papers)Cancer Cell (1 paper)
- Partner nations
- United StatesUkraineSpain
In The Last Decade
Mark A. Gregory
21 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 80
- Hematology 335
- Cancer Research 360
- Molecular Biology 1.5k
- Oncology 567
- Genetics 141
Countries citing papers authored by Mark A. Gregory
This map shows the geographic impact of Mark A. Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Gregory more than expected).
Fields of papers citing papers by Mark A. Gregory
This network shows the impact of papers produced by Mark A. Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Gregory. The network helps show where Mark A. Gregory may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Gregory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 375 | |
| 2 | 2003 | 357 | |
| 3 | 2004 | 255 | |
| 4 | 2004 | 172 | |
| 5 | 2010 | 141 | |
| 6 | 2019 | 127 | |
| 7 | 2016 | 81 | |
| 8 | 2017 | 65 | |
| 9 | 2013 | 58 | |
| 10 | 2014 | 56 | |
| 11 | 2012 | 37 | |
| 12 | 2000 | 34 | |
| 13 | 2012 | 33 | |
| 14 | 2004 | 25 | |
| 15 | 2022 | 18 | |
| 16 | 2000 | 16 | |
| 17 | 2014 | 12 | |
| 18 | 2012 | 11 | |
| 19 | 2023 | 2 | |
| 20 | 2021 | 1 |
About Mark A. Gregory
Mark A. Gregory is a scholar working on Molecular Biology, Hematology, Oncology, Cancer Research and Rheumatology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Ubiquitin and proteasome pathways (6 papers), Cancer-related Molecular Pathways (5 papers), Cell death mechanisms and regulation (5 papers), Histone Deacetylase Inhibitors Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Protein Degradation and Inhibitors (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Hematology (335 citations), Cancer Research (360 citations), Molecular Biology (1.5k citations), Oncology (567 citations) and Genetics (141 citations). Mark A. Gregory has collaborated with scholars based in United States, Ukraine and Spain. Frequent co-authors include Stephan Hann, Ying Qi, Julie A. Vrana, Aaron M. Domina, Ruth W. Craig, James DeGregori, Vadym Zaberezhnyy, Ying Qi, Jeffrey P. Brousal and Angelo D’Alessandro. Their work appears in journals such as Clinical Cancer Research, Oncogene, Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.